Medical Matters

Access to medical care for U.S. adults, particularly among the uninsured, decreased between 2000 and 2010 according to a new report released by the Robert Wood Johnson Foundation. The state-by-state report analyzed access to health care among non-elderly adults age 19-64 using three measures of access — unmet needs due to cost, receipt of a routine medical checkup and receipt of a routine dental checkup — and found that all three measures decreased in nearly every state during the time period measured.

The report, authored by the Urban Institute, indicated the uninsured were much less likely to receive services due to cost than their insured counterparts. In 2010, 48% of the uninsured lacked access to health care due to unmet cost, while 11% of those with insurance faced this barrier.

“At the end of the decade, the uninsured in every state were at a dramatic disadvantage relative to the insured across the three access measures we examined. It appears that the health care safety net that is designed,
in part, to serve those without coverage is not acting as an effective substitute for health insurance in any state when it comes to meeting health care needs and providing basic health care services,” the report stated.

While most states exhibited declines in every access measure, Washington D.C. and West Virginia showed no statistically significant declines in any access measure. Thirteen states showed decreased access in all three measures, while 17 states showed decreases in two measures.

The study authors conclude, “[T]he ACA [Affordable Care Act] coverage expansion has the potential to reduce unmet needs due to costs and other cost-related barriers, problems that are more severe in states with high uninsurance rates.”

Share

{ 0 comments }

AHCJ 2012 Recap

by Elizabeth on April 23, 2012

As a writer new to health reporting — and I mean Reporting with a J-school capital ‘R’ — I learned a lot at Health Journalism 2012, the annual conference of the Association of Health Care Journalists. Here are my impressions and random takeaways from the conference.

  1. Befriend a biostatistician. From the Evaluating medical evidence for journalists session by Gary Schwitzer of Health News Review and Ivan Oransky of Reuters Health. You know all that numbers crap you see in drug advertisements and medical studies? It matters. It matters a lot. Learn the difference between absolute and relative risk/benefit data. And if you’re “really bad at math,” don’t despair. Use a calculator and the tookit at Health News Review.
  2. New Mexico currently ranks #1 in a Google search on the term “allergies.” I know this because: a) the nice lady presenting Google tools for health reporters showed us a slide that bore out this fact, and b) because I live in Albuquerque and am eating Zyrtec like candy these days. (Do not try this at home.) You can discover similar trend info by using Google Insights for Search. She also told us about Google+ for Media. Who knew?
  3. There will be free, open sessions at the Alzheimer’s Research Summit May 14-15, 2012. This, via Dr. Buckholtz at the session Is earlier diagnosis of Alzheimer’s around the corner? (Maybe/maybe not, by the way.) Anyone can attend the public sessions, but you have to register in advance. So if you live in the Bethesda, Maryland, area: GO. Whether, like me, you cover the Alzheimer’s beat or you’re a concerned citizen, get the info and give your input. This stuff’s important.
  4. It’s OK to stalk editors via Twitter. At least, it’s OK to stalk some of them. So says Brendan Maher, features editor of Nature, who participated in the Freelance: Pitches that are a hit with editors session. Other tips from various participating editors: Read the magazine you’re pitching before you pitch it. (I say: If you don’t already know that, take a Freelancing 101 course, please.) Also, flattery works but obsequiousness may cross the line. And if you do get a bite from an editor, don’t be afraid to ask about money. If the editor requires you to read and cite “10-15 research studies” for a short, one-pager FOB piece, $2/word maybe ain’t all that much. [Edited to clarify: Brendan was one among several editors fielding freelancer questions that day. An audience member (not yours truly) seemed to have an issue with the $2/word pay rate offered by a different publication and spoke up rather forcefully about it.]
  5. Jimmy Carter is still a darn fine gentleman. He’s witty, candid, and down-to-earth. Oh, and did I mention smart? And savvy? But you’d expect that from a former president. His lovely wife, Rosalynn, remains as gracious as you’d imagine and continues to champion a cause that’s dear to my own heart: parity in mental health treatment. Their efforts via the Carter Center have nearly wiped Guinea worm off the face of the earth, and they’re pushing to get the Mental Health Parity Act, which was passed by Congress two years ago, implemented. What’s the holdup?

But the biggest takeaway for health reporters at Health Journalism 2012 was this: membership in AHCJ is worth every penny. Among the many benefits: resources, tools, fellowships, an affordable annual conference, and a great bunch of helpful fellow members who share freely on the listserv. I’m so glad I joined. And I can’t wait for #AHCJ13.

Share

{ 0 comments }

Alzheimer’s Association recruits volunteers for clinical trials

February 24, 2012

Conquering any disease requires medical research, and plenty of it. A tool offered by the Alzheimer’s Association makes it easier to recruit participants and physicians for clinical trials in hopes of finding a clear cause and, ultimately, a cure for this disease that takes so much from so many. TrialMatch is a continuously updated database [...]

Share
Read the full article →

PPI use possibly associated with C. diff diarrhea

February 8, 2012

The FDA issued a drug safety communication today advising that the use of proton pump inhibitors (PPIs) may be associated with Clostridium difficile-associated diarrhea (CDAD). Proton pump inhibitors are medications designed to decrease stomach acid production and are often used to treat heartburn, gastroesophogeal reflux disease (GERD), and ulcers of the intestines. PPIs are available [...]

Share
Read the full article →

High triglyceride levels? Hie thee to a doctor, woman!

February 7, 2012

Older women worried about stroke should check their triglyceride levels, according to a new study conducted by researchers at Albert Einstein College of Medicine of Yeshiva University and NYU School of Medicine. The study examined the roles of individual lipid biomarkers (HDL and LDL cholesterol, along with triglycerides) and found that total cholesterol and LDL [...]

Share
Read the full article →

Don’t know what questions to ask the doctor? Start here.

January 27, 2012

Patients may want to take more responsibility for their health but have difficulty knowing what questions to ask their doctor during a visit. Or they may have some questions in mind but forget to ask them. To address this problem, the Agency for Healthcare Research and Quality has rolled out an interactive tool that helps [...]

Share
Read the full article →

When it comes to health screenings, be proactive

January 25, 2012

Don’t rely on your doctor to suggest all the recommended health screenings you may need. That’s the conclusion of a new study by researchers at Virginia Commonwealth University. The study found less than half of the 20% of adults who attended periodic health examinations each year received counseling or recommendations from their doctors to complete [...]

Share
Read the full article →

Should you ditch the small-plate theory of calorie reduction?

January 23, 2012

I’m not sure what to make of this study, published in the Journal of Human Nutrition and Dietetics. Some background: using a smaller plate has been a traditional recommendation for those wishing to reduce calorie intake. The rationale behind this advice is multi-fold. First, a small plate theoretically holds fewer calories than a large plate. [...]

Share
Read the full article →

New chemical probe shows promise for diagnosing Alzheimer’s disease

January 22, 2012

A newly developed chemical agent shows promise for diagnosing Alzheimer’s disease through imaging scans, according to a study published in ACS Medicinal Letters. Previously, the only definitive way to diagnose Alzheimer’s was through postmortem histological examination of brain tissues to identify the tau protein tangles that typically identify this disease. A team of researchers at [...]

Share
Read the full article →